Cargando…
The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Thoracic Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047458/ https://www.ncbi.nlm.nih.gov/pubmed/31816247 http://dx.doi.org/10.1164/rccm.201911-2258ED |
| _version_ | 1783502146474344448 |
|---|---|
| author | Abubakar, Ibrahim Cobelens, Frank G. J. Rangaka, Molebogeng X. |
| author_facet | Abubakar, Ibrahim Cobelens, Frank G. J. Rangaka, Molebogeng X. |
| author_sort | Abubakar, Ibrahim |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7047458 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Thoracic Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70474582020-03-01 The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials Abubakar, Ibrahim Cobelens, Frank G. J. Rangaka, Molebogeng X. Am J Respir Crit Care Med Editorials American Thoracic Society 2020-03-01 2020-03-01 /pmc/articles/PMC7047458/ /pubmed/31816247 http://dx.doi.org/10.1164/rccm.201911-2258ED Text en Copyright © 2020 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org). |
| spellingShingle | Editorials Abubakar, Ibrahim Cobelens, Frank G. J. Rangaka, Molebogeng X. The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials |
| title | The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials |
| title_full | The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials |
| title_fullStr | The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials |
| title_full_unstemmed | The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials |
| title_short | The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials |
| title_sort | risk of falsely declaring noninferiority of novel latent tuberculosis treatment in large trials |
| topic | Editorials |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047458/ https://www.ncbi.nlm.nih.gov/pubmed/31816247 http://dx.doi.org/10.1164/rccm.201911-2258ED |
| work_keys_str_mv | AT abubakaribrahim theriskoffalselydeclaringnoninferiorityofnovellatenttuberculosistreatmentinlargetrials AT cobelensfrankgj theriskoffalselydeclaringnoninferiorityofnovellatenttuberculosistreatmentinlargetrials AT rangakamolebogengx theriskoffalselydeclaringnoninferiorityofnovellatenttuberculosistreatmentinlargetrials AT abubakaribrahim riskoffalselydeclaringnoninferiorityofnovellatenttuberculosistreatmentinlargetrials AT cobelensfrankgj riskoffalselydeclaringnoninferiorityofnovellatenttuberculosistreatmentinlargetrials AT rangakamolebogengx riskoffalselydeclaringnoninferiorityofnovellatenttuberculosistreatmentinlargetrials |